Published in N Engl J Med on September 21, 1967
Euglycaemic diabetic ketoacidosis. Br Med J (1973) 1.66
Acidaemia and salicylate poisoning in adults. Br Med J (1969) 1.25
Central nervous system pH in uremia and the effects of hemodialysis. J Clin Invest (1976) 1.08
Hyperglycaemic crises and lactic acidosis in diabetes mellitus. Postgrad Med J (2004) 1.06
Signs and symptoms of electrolyte disorders. Yale J Biol Med (1970) 1.04
Unexpected death during treatment of uncomplicated diabetic ketoacidosis. Br Med J (1968) 0.95
Bicarbonate in diabetic ketoacidosis - a systematic review. Ann Intensive Care (2011) 0.95
Sodium bicarbonate therapy in patients with metabolic acidosis. ScientificWorldJournal (2014) 0.94
Successful resuscitation in diabetic ketoacidosis: a strong case for the use of bicarbonate. Postgrad Med J (1974) 0.81
Ammonia metabolism in chronic obstructive pulmonary disease with special reference to congestive right ventricular failure. Thorax (1974) 0.77
Infusion of sodium bicarbonate in experimentally induced metabolic acidosis does not provoke cerebrospinal fluid (CSF) acidosis in calves. Can J Vet Res (2012) 0.77
Diabetic ketoacidosis presenting as neurosurgical emergencies. Br Med J (1974) 0.75
Letter: Cerebral oedema in diabetic ketoacidosis. Br Med J (1975) 0.75
Coincidental changes in conscious level and lens translucency during treatment of diabetic ketoacidosis. Br J Ophthalmol (1975) 0.75
Acid base balance in blood and cerebrospinal fluid. Arch Dis Child (1985) 0.75
The management of diabetic acidosis. West J Med (1977) 0.75
Cerebral syndromes of diabetes mellitus. Calif Med (1969) 0.75
The Role of Sodium Bicarbonate in the Management of Some Toxic Ingestions. Int J Nephrol (2017) 0.75
Persistent vegetative state after brain damage. A syndrome in search of a name. Lancet (1972) 10.56
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain (2000) 7.95
Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol (1983) 5.98
Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol (1982) 5.58
Behavioural improvements with thalamic stimulation after severe traumatic brain injury. Nature (2007) 4.99
Prognosis in nontraumatic coma. Ann Intern Med (1981) 4.89
Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer (1982) 4.40
A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med (1999) 3.58
Predicting outcome from hypoxic-ischemic coma. JAMA (1985) 3.48
HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell (1991) 3.33
Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) (1992) 3.21
Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology (1992) 3.11
Distribution of brain metastases. Arch Neurol (1988) 3.11
Epidural spinal cord compression from metastatic tumor: diagnosis and treatment. Ann Neurol (1978) 3.08
fMRI reveals large-scale network activation in minimally conscious patients. Neurology (2005) 2.82
Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron (1993) 2.81
Editorial: The lumbar puncture. N Engl J Med (1974) 2.65
Radiation-induced dementia in patients cured of brain metastases. Neurology (1989) 2.59
Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer--a quantitative western blot analysis. Ann Neurol (1990) 2.58
Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med (1990) 2.54
A prospective study of nontraumatic coma: methods and results in 310 patients. Ann Neurol (1977) 2.45
Cerebrovascular complications in patients with cancer. Medicine (Baltimore) (1985) 2.39
Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain (1999) 2.35
Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. Arch Neurol (1974) 2.33
Biochemistry and physiology of brain ammonia. Physiol Rev (1987) 2.30
Effect of brain irradiation on demyelinating lesions. Neurology (1993) 2.21
Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol (1997) 2.19
Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies. Neurology (2000) 2.17
Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol (2001) 2.15
Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology (1979) 2.13
Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology (1987) 2.12
Spontaneous recurrent hypothermia accompanying agenesis of the corpus callosum. Brain (1969) 2.10
Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A (1987) 2.05
Intracranial metastases from systemic cancer. Adv Neurol (1978) 1.92
The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am J Pathol (1992) 1.91
Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology (1982) 1.88
Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology (1985) 1.86
Motor neuron syndromes in cancer patients. Ann Neurol (1997) 1.82
Generalized muscular stiffness, fasciculations, and myokymia of peripheral nerve origin. Arch Neurol (1970) 1.82
MRI changes in intracranial hypotension. Neurology (1993) 1.80
Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med (1986) 1.79
Subacute encephalitis in acquired immune deficiency syndrome: a postmortem study. Am J Clin Pathol (1984) 1.79
What causes infarction in ischemic brain?: The Robert Wartenberg Lecture. Neurology (1983) 1.75
Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain (1997) 1.73
Brachial plexus lesions in patients with cancer: 100 cases. Neurology (1981) 1.70
Radiation therapy for brain metastases. Ann Neurol (1980) 1.68
Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol. Ann Neurol (1980) 1.68
Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology (1988) 1.66
Cerebral metabolic and circulatory responses to induced convulsions in animals. Arch Neurol (1968) 1.66
Magnetic resonance imaging measurements and clinical changes accompanying transtentorial and foramen magnum brain herniation. Ann Neurol (1993) 1.65
The vegetative state and its prognosis following nontraumatic coma. Ann N Y Acad Sci (1978) 1.65
Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology (1990) 1.65
Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol (1988) 1.63
Metastasis to the base of the skull: clinical findings in 43 patients. Neurology (1981) 1.61
Perforation of the gastrointestinal tract in patients receiving steroids for neurologic disease. Neurology (1988) 1.59
Subacute sensory neuropathy: a remote effect of carcinoma. Ann Neurol (1977) 1.58
Steroid myopathy in cancer patients. Neurology (1997) 1.57
Ataxia in epidural spinal cord compression. Neurology (1992) 1.55
Neurologic complications of carcinoid. Neurology (1986) 1.54
Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus. Am J Med (1983) 1.53
Hydrogen ions kill brain at concentrations reached in ischemia. J Cereb Blood Flow Metab (1987) 1.47
Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. Ann Neurol (1985) 1.46
Subacute motor neuronopathy: a remote effect of lymphoma. Ann Neurol (1979) 1.42
Differences in cerebral blood flow and glucose utilization in vegetative versus locked-in patients. Ann Neurol (1987) 1.42
Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology (1992) 1.41
Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc Natl Acad Sci U S A (1991) 1.41
The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery (1989) 1.40
Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. Neurology (1986) 1.39
Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Ann Neurol (1995) 1.37
Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer (1995) 1.36
Swallow syncope. Report of a case and review of the literature. Neurology (1972) 1.35
Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Medicine (Baltimore) (1988) 1.35
Central nervous system infections in patients with cancer. Medicine (Baltimore) (1973) 1.34
Hyperphagia, rage, and dementia accompanying a ventromedial hypothalamic neoplasm. Arch Neurol (1969) 1.33
Management of central nervous system metastases. Semin Oncol (1977) 1.32
Carbonic acid buffer changes during complete brain ischemia. Am J Physiol (1986) 1.32
Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri): the case for a nomenclature based on antibody and antigen specificity. Neurology (1994) 1.32
Selective chromatolysis of neurons in the gerbil brain: a possible consequence of "epileptic" activity produced by common carotid artery occlusion. Ann Neurol (1979) 1.27
The diagnosis of stupor and coma. Contemp Neurol Ser (1972) 1.26
Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology (1991) 1.26
Vulnerability of developing rat brain to electroconvulsive seizures. Arch Neurol (1973) 1.25
Headaches in patients with brain tumors: a study of 111 patients. Neurology (1993) 1.25
The role of arousal and "gating" systems in the neurology of impaired consciousness. J Clin Neurophysiol (2000) 1.25
The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J Clin Invest (1979) 1.24
Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology (1988) 1.22
Necrotizing encephalopathy following intraventricular instillation of methotrexate. Arch Neurol (1973) 1.22
Hyponatremia in acute polyneuropathy. Four cases with the syndrome of inappropriate secretion of antidiuretic hormone. Arch Neurol (1967) 1.21
Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease. Neurology (1992) 1.21
Brain metastasis from melanoma. J Neurooncol (1983) 1.21
Hydrogen ion buffering during complete brain ischemia. Brain Res (1985) 1.20
Cerebellar degeneration-related antigen: a highly conserved neuroectodermal marker mapped to chromosomes X in human and mouse. Proc Natl Acad Sci U S A (1990) 1.19
Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology (1988) 1.19
Immunological and pathological study of anti-Ri-associated encephalopathy. Ann Neurol (1994) 1.19
Human brain tumor transplantation into nude mice. J Natl Cancer Inst (1979) 1.18
Cerebral oxidative metabolism and blood flow during acute hypoglycemia and recovery in unanesthetized rats. J Neurochem (1982) 1.18
T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis. Neurology (1998) 1.18
Spinal subdural hematomas complicating lumbar puncture. Arch Neurol (1974) 1.17
Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. Acta Neuropathol (1996) 1.16